Condition
Recurrent Pericarditis clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Pericarditis clinical trials that are recruiting, at sites in 11 countries (most in Canada (4), Greece (4), United States (4)). By phase: Phase 2 (2), Phase 3 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 11Countries
Newest Recurrent Pericarditis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Transitioning people with recurrent pericarditis to KPL-387 monotherapy dosing and administration | Phase 2 | Phoenix, Arizona and 47 other locations | Recruiting | Dec 17, 2025 |
| KPL-387 for recurrent pericarditis | Phase 2/3 | Gilbert, Arizona and 66 other locations | Recruiting | Jun 8, 2025 |
| Testing VTX2735 for treating recurrent pericarditis | Phase 2 | La Jolla, California and 19 other locations | Recruiting | Feb 20, 2025 |
| Using CardiolRx for patients with recurrent pericarditis after stopping IL-1 blockers | Phase 3 | Phoenix, Arizona and 26 other locations | Recruiting | Nov 27, 2024 |
All recruiting trials (4)
-
Transitioning people with recurrent pericarditis to KPL-387 monotherapy dosing and administration
This trial will try switching people with well-controlled recurrent pericarditis from their current therapies to KPL-387 alone for up to 16 weeks to see if symptoms and inflammation stay controlled and the drug is tolerable.
-
KPL-387 for recurrent pericarditis
This trial tests whether KPL-387 can control pain and inflammation and lower the chance of future attacks in people having an acute episode of recurrent pericarditis despite standard treatment.
-
Testing VTX2735 for treating recurrent pericarditis
This study is testing a new drug called VTX2735 to see if it can help people with recurrent pericarditis feel better and reduce their symptoms.
-
Using CardiolRx for patients with recurrent pericarditis after stopping IL-1 blockers
This study is testing if CardiolRx can help people with recurrent pericarditis avoid flare-ups after they stop taking IL-1 blocker therapy.
Related topics
Quick answers
How many Recurrent Pericarditis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in Canada (4 trials), Greece (4 trials), United States (4 trials), Italy (3 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.